AAAAAA
Results:
1-14
|
Results: 14
Authors:
Kotala, V
Uldrijan, S
Horky, M
Trbusek, M
Strnad, M
Vojtesek, B
Citation: V. Kotala et al., Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases, CELL MOL L, 58(9), 2001, pp. 1333-1339
Authors:
Horky, M
Wurzer, G
Kotala, V
Anton, M
Vojtesek, B
Vacha, J
Wesierska-Gadek, J
Citation: M. Horky et al., Segregation of nucleolar components coincides with caspase-3 activation incisplatin-treated HeLa cells, J CELL SCI, 114(4), 2001, pp. 663-670
Authors:
Blaydes, JP
Luciani, MG
Pospisilova, S
Ball, HML
Vojtesek, B
Hupp, TR
Citation: Jp. Blaydes et al., Stoichiometric phosphorylation of human p53 at Ser(315) stimulates p53-dependent transcription, J BIOL CHEM, 276(7), 2001, pp. 4699-4708
Authors:
Pospisilova, S
Kankova, K
Svitakova, M
Nenutil, R
Vojtesek, B
Citation: S. Pospisilova et al., New monoclonal antibodies recognizing p53 protein phosphorylated by caseinkinase II at Serine 392, FOL BIOL, 47(4), 2001, pp. 148-151
Authors:
Kolar, Z
Murray, PG
Scott, K
Harrison, A
Vojtesek, B
Dusek, J
Citation: Z. Kolar et al., Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer, J CL PATH-M, 53(1), 2000, pp. 15-18
Authors:
Fojta, M
Brazdova, M
Cernocka, H
Pecinka, P
Brazda, V
Palecek, J
Jagelska, E
Vojtesek, B
Pospisilova, S
Subramaniam, V
Jovin, TM
Palecek, E
Citation: M. Fojta et al., Effects of oxidation agents and metal ions on binding of p53 to supercoiled DNA, J BIO STRUC, 2000, pp. 177-183
Authors:
Kolar, Z
Flavell, JR
Ehrmann, J
Rihakova, P
Macak, J
Lowe, D
Crocker, J
Vojtesek, B
Young, LS
Murray, PG
Citation: Z. Kolar et al., Apoptosis of malignant cells in Hodgkin's disease is related to expressionof the cdk inhibitor p27KIP1, J PATHOLOGY, 190(5), 2000, pp. 604-612
Authors:
Pospisilova, S
Brazda, V
Amrichova, J
Kamermeierova, R
Palecek, E
Vojtesek, B
Citation: S. Pospisilova et al., Precise characterisation of monoclonal antibodies to the C-terminal regionof p53 protein using the PEPSCAN ELISA technique and a new non-radioactivegel shift assay, J IMMUNOL M, 237(1-2), 2000, pp. 51-64
Authors:
Brazda, V
Palecek, J
Pospisilova, S
Vojtesek, B
Palecek, E
Citation: V. Brazda et al., Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies, BIOC BIOP R, 267(3), 2000, pp. 934-939
Authors:
Blaydes, JP
Vojtesek, B
Bloomberg, GB
Hupp, TR
Citation: Jp. Blaydes et al., The development and use of phospho-specific antibodies to study protein phosphorylation, METH MOL B, 99, 2000, pp. 177-189
Authors:
Smart, P
Lane, EB
Lane, DP
Midgley, C
Vojtesek, B
Lain, S
Citation: P. Smart et al., Effects on normal fibroblasts and neuroblastoma cells of the activation ofthe p53 response by the nuclear export inhibitor leptomycin B, ONCOGENE, 18(51), 1999, pp. 7378-7386
Authors:
Palecek, E
Brazdova, M
Cernocka, H
Vlk, D
Brazda, V
Vojtesek, B
Citation: E. Palecek et al., Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments, ONCOGENE, 18(24), 1999, pp. 3617-3625
Authors:
Craig, AL
Burch, L
Vojtesek, B
Mikutowska, J
Thompson, A
Hupp, TR
Citation: Al. Craig et al., Novel phosphorylation sites of human tumour suppressor protein p53 at Ser(20) and Thr(18) that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers, BIOCHEM J, 342, 1999, pp. 133-141
Authors:
Fojta, M
Kubicarova, T
Vojtesek, B
Palecek, E
Citation: M. Fojta et al., Effect of p53 protein redox states on binding to supercoiled and linear DNA, J BIOL CHEM, 274(36), 1999, pp. 25749-25755
Risultati:
1-14
|